Repeat prenatal corticosteroid doses do not alter neonatal blood pressure or myocardial thickness: Randomized, controlled trial

Pediatrics

Volumn 123, Issue 4, 2009, Pages

  Mildenhall, Lindsay ^a   Battin, Malcolm ^b   Bevan, Coila ^d   Kuschel, Carl ^d   Harding, Jane E ^c  

^a MIDDLEMORE HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d National Women's Health   (New Zealand)

Author keywords

Betamethasone; Cardiovascular status; Glucocorticoids; Heart; Infant; Newborn; Prematurity

Indexed keywords

BETAMETHASONE; PLACEBO; GLUCOCORTICOID;

ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; FEMALE; GESTATIONAL AGE; HEART MUSCLE; HEART VENTRICLE SEPTUM; HOSPITAL DISCHARGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPEATED DRUG DOSE; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; ADULT; BLOOD PRESSURE; CARDIOMEGALY; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; HEART; MULTICENTER STUDY; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; PATHOLOGY; PREGNANCY; PRENATAL EXPOSURE; RETREATMENT;

ADULT; BETAMETHASONE; BLOOD PRESSURE; CARDIOMEGALY; DOUBLE-BLIND METHOD; FEMALE; GLUCOCORTICOIDS; HEART; HUMANS; INFANT, NEWBORN; MYOCARDIUM; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RETREATMENT;

EID: 65349135325     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-1931     Document Type: Article

References (35)

1. Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev. 2006;(3):CD000065
2. McLaughlin KJ, Crowther CA, Walker N, Harding JE. Effects of a single course of corticosteroids given more than 7 days before birth: a systematic review. Aust N Z J Obstet Gynaecol. 2003; 43(2):101-106 (Pubitemid 36626109)
3. Crowther CA, Harding JE. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. Cochrane Database Syst Rev. 2007;(3): CD003935
4. Werner JC, Sicard RE, Hansen TW, Solomon E, Cowett RM, Oh W. Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia. J Pediatr. 1992; 120(2):286-291
5. Brand PL, van Lingen RA, Brus F, Talsma MD, Elzenga NJ. Hypertrophic obstructive cardiomyopathy as a side effect of dexamethasone treatment for bronchopulmonary dysplasia. Acta Paediatr. 1993;82(6-7):614-617 (Pubitemid 23188668)
6. Moïse AA, Wearden ME, Kozinetz CA, Gest AL, Welty SE, Hansen TN. Antenatal steroids are associated with less need for blood pressure support in extremely premature infants. Pediatrics. 1995;95(6):845-850
7. Demarini S, Dollberg S, Hoath SB, Ho M, Donovan EF. Effects of antenatal corticosteroids on blood pressure in very low birth weight infants during the first 24 hours of life. J Perinatol. 1999;19(6):419-425
8. Elimian A, Figueroa R, Spitzer AR, Ogburn PL, Wiencek V, Quirk JG. Antenatal corticosteroids: are incomplete courses beneficial? Obstet Gynecol. 2003;102(2):352-355 (Pubitemid 36937010)
9. Mildenhall LF, Battin MR, Morton SM, Bevan C, Kuschel CA, Harding JE. Exposure to repeat doses of antenatal glucocorticoids is associated with altered cardiovascular status after birth. Arch Dis Child Fetal Neonatal Ed. 2006;91(1):F56-F60 (Pubitemid 43059204)
10. Vural M, Yilmaz I, Oztunç F, Ilikkan B, Erginöz E, Perk Y. Cardiac effects of a single course of antenatal betamethasone in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2006;91(2): F118-F122 (Pubitemid 43325530)
11. Crowther CA, Haslam RR, Hiller JE, Doyle LW, Robinson JS; Australasian Collaborative Trial of Repeat Doses of Steroids (ACTORDS) Study Group. Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial. Lancet. 2006;367(9526): 1913-1919
12. Crowther CA, Doyle LW, Haslam RR, et al. Outcomes at 2 years of age after repeat doses of antenatal corticosteroids. N Engl J Med. 2007;357(12):1179-1189 (Pubitemid 47443177)
13. Zubrow AB, Hulman S, Kushner H, Falkner B. Determinants of blood pressure in infants admitted to neonatal intensive care units: a prospective multicenter study. J Perinatol. 1995;15(6): 470-479
14. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978; 58(6):1072-1083 (Pubitemid 9091990)
15. Solinger R, Elbl F, Minhas K. Echocardiography in the normal neonate. Circulation. 1973;47(1):108-118
16. Walther FJ, Siassi B, King J, Wu PY. Echocardiographic measurements in normal preterm and term neonates. Acta Paediatr Scand. 1986;75(4):563-568 (Pubitemid 16100482)
17. Skelton R, Gill AB, Parsons JM. Reference ranges for cardiac dimensions and blood flow velocity in preterm infants. Heart. 1998;80(3):281-285 (Pubitemid 28440348)
18. Seliem WA, Falk MC, Shadbolt B, Kent AL. Antenatal and postnatal risk factors for neonatal hypertension and infant follow-up. Pediatr Nephrol. 2007;22(12):2081-2087 (Pubitemid 350090715)
19. Skelton R, Gill AB, Parsons JM. Cardiac effects of short course dexamethasone in preterm infants. Arch Dis Child Fetal Neonatal Ed. 1998;78(2):F133-F137 (Pubitemid 28201562)
20. Evans N. Cardiovascular effects of dexamethasone in the preterm infant. Arch Dis Child Fetal Neonatal Ed. 1994;70(1): F25-F30 (Pubitemid 24087303)
21. Yunis KA, Bitar FF, Hayek P, Mroueh SM, Mikati M. Transient hypertrophic cardiomyopathy in the newborn following multiple doses of antenatal corticosteroids. Am J Perinatol. 1999; 16(1):17-21 (Pubitemid 29211383)
22. Marinelli KA, Burke GS, Herson VC. Effects of dexamethasone on blood pressure in premature infants with bronchopulmonary dysplasia. J Pediatr. 1997;130(4):594-602 (Pubitemid 27492651)
23. Bloomfield FH, Knight DB, Harding JE. Side effects of 2 different dexamethasone courses for preterm infants at risk of chronic lung disease: a randomized trial. J Pediatr. 1998;133(3): 395-400 (Pubitemid 28413625)
24. Moss TJ, Harding R, Newnham JP. Lung function, arterial pressure and growth in sheep during early postnatal life following single and repeated prenatal corticosteroid treatments. Early Hum Dev. 2002;66(1):11-24 (Pubitemid 34123284)
25. Moss TJ, Doherty DA, Nitsos I, Sloboda DM, Harding R, Newnham JP. Effects into adulthood of single or repeated antenatal corticosteroids in sheep. Am J Obstet Gynecol. 2005;192(1): 146-152 (Pubitemid 40164234)
26. Benediktsson R, Lindsay RS. Glucocorticoid exposure in utero: new model for adult hypertension. Lancet. 1993;341(8841): 339-341 (Pubitemid 23039701)
27. Levitt NS, Lindsay RS, Holmes MC, Seckl JR. Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat. Neuroendocrinology. 1996; 64(6):412-418 (Pubitemid 27007194)
28. Dodic M, Samuel C, Moritz K, et al. Impaired cardiac functional reserve and left ventricular hypertrophy in adult sheep after prenatal dexamethasone exposure. Circ Res. 2001;89(7): 623-629 (Pubitemid 32924217)
29. Dodic M, Moritz K, Wintour EM. Prenatal exposure to glucocorticoids and adult disease. Arch Physiol Biochem. 2003; 111(1):61-69 (Pubitemid 36398901)
30. Banjanin S, Kapoor A, Matthews SG. Prenatal glucocorticoid exposure alters hypothalamic-pituitary-adrenal function and blood pressure in mature male guinea pigs. J Physiol. 2004; 558(1):305-318 (Pubitemid 39077410)
31. Figueroa JP, Rose JC, Massmann GA, Zhang J, Acuna G. Alterations in fetal kidney development and elevations in arterial blood pressure in young adult sheep after clinical doses of antenatal glucocorticoids. Pediatr Res. 2005;58(3):510-515 (Pubitemid 41254516)
32. Sloboda DM, Moss TJ, Gurrin LC, Newnham JP, Challis JR. The effect of prenatal betamethasone administration on postnatal ovine hypothalamic-pituitary- adrenal function. J Endocrinol. 2002;172(1):71-81 (Pubitemid 34082946)
33. Dessens AB, Haas HS, Koppe JG. Twenty-year follow-up of antenatal corticosteroid treatment. Pediatrics. 2000;105(6). Available at: www.pediatrics.org/cgi/content/full/105/6/ e77
34. Dalziel SR, Walker NK, Parag V, et al. Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial. Lancet. 2005; 365(9474):1856-1862 (Pubitemid 40744963)
35. Wapner RJ, Sorokin Y, Mele L, et al. Long-term outcomes after repeat doses of antenatal corticosteroids. N Engl J Med. 2007; 357(12):1190-1198 (Pubitemid 47443178)